News Category
Viromed Medical AG has received approval for its ViroCAP® med cold plasma device in Turkey ahead of schedule, securing binding orders and marking a ke...
Heidelberg Pharma will present new clinical data on its lead ATAC candidate, pamlectabart tismanitin (HDP-101), and its second candidate, HDP-102, at ...
Tonix Pharmaceuticals will present at Guggenheim's 3rd Annual Healthcare Innovation Conference on Nov. 10, 2026, providing investors an update on its ...
Quantum BioPharma advances a broad strategy combining drug development, consumer wellness, and royalty partnerships to address the massive unmet need ...
Wellness Eternal's October 2026 Wellness Index Report highlights three experts who are shifting the focus from hoping for a longer, healthier life to ...
Sequencio Therapeutics, a CK Life Sciences subsidiary, will present preclinical data at SITC 2026 showing its TROP2 and PD-L1/PRAME cancer vaccines ge...
Quantum BioPharma's unbuzzd supplement, designed to support alcohol metabolism, has been highlighted by Men's Fitness after a small placebo-controlled...
Kairos Pharma's ENV-105 demonstrated a statistically significant improvement in progression-free survival for metastatic castration-resistant prostate...
Adaptogenics Health Corp. is building its peptide strategy around supply verification and traceability as U.S. regulators advance an interim access po...
Quantum BioPharma's unbuzzd supplement drink, designed to support alcohol metabolism, has drawn attention from Men's Fitness after a clinical trial sh...
ABVC BioPharma's $3.39 million private placement of original issue discount senior convertible notes will fund working capital, subsidiary development...
Tonix Pharmaceuticals appoints George Lederman as EVP of strategy and transformation to drive AI initiatives and business development, a move that cou...
Okogen has dosed the first patient in its Phase 1/2 EMERALD Trial of Treyegen, a potential single therapy for acute infectious conjunctivitis, marking...
Catherine Cifuentes-Rojas, a biotherapeutics veteran now at Ginkgo Bioworks, has released a free five-question go/no-go checklist to help discovery te...
VERAXA Biotech is expanding its use of human-relevant preclinical testing methods, including 3D tumor spheroid and patient-derived tumor models, to im...
Quantum BioPharma has signed a Study Start-Up Agreement with Thermo Fisher Scientific's clinical research business to advance its Phase 2 trial of Luc...
A preclinical study of a dual-impact antibody that combats multiple tumor types in mice could widen the reach of immunotherapy, which has had profound...
A new federal policy allowing licensed pharmacies and physicians to compound six previously restricted peptides without FDA enforcement action could l...
Helix BioPharma Corp. reported a reduced net loss of $3.35 million for fiscal 2026 but disclosed a working capital deficiency and cash reserves insuff...
Regentis Biomaterials is advancing its GelrinC hydrogel implant for knee cartilage repair, with strong clinical data and a CE mark in Europe, as it pr...
Annovis Bio CEO Maria Maccecchini will present at two November biotechnology conferences, highlighting the company's clinical programs for Alzheimer's...
Oncotelic Therapeutics is scaling its PLA-guided discovery engine toward a 100-billion-vector protein program after a published liver cancer study val...
TransCode Therapeutics has initiated a formal strategic review to evaluate options for maximizing value, including potential licensing, partnerships, ...
Certified-PEP's 2026 comparison of 10 research peptide suppliers reveals significant differences in documentation transparency, underscoring the need ...
Enodia Therapeutics has appointed Henrik Torp Nielsen as Chief Financial Officer to lead financial strategy as the company advances its proprietary Se...
A Phase 3 trial shows that combining two immunotherapy drugs significantly extends survival in patients with a deadly form of lung cancer, offering ne...
VolitionRx has signed a nonbinding LOI with Missionpharma to develop and commercialize a lateral flow test for NETosis, initially targeting neonatal s...
Creative Biolabs is promoting its CH50 functional test kit, hemolysis inhibition profiling service, and flow focusing droplet generation chip to help ...
NanoViricides reports progress in its Phase IIA trial of NV-387 Oral Gummies for Ebola Bundibugyo virus disease in the DRC, where over 10,000 cases an...
A mutated flu version is driving an earlier-than-expected outbreak on the West Coast, prompting experts to call for urgent vaccination drives and high...
Tonix Pharmaceuticals presented Phase 3 data at the IASP 2026 World Congress showing its newly approved fibromyalgia drug TONMYA significantly improve...
GeoVax Labs has entered a $1 million revolving loan agreement with Bowery Consulting Group, a deal that reshapes its board with three lender-nominated...
Creative Biolabs is promoting three-dimensional tumor organoid co-culture services that let preclinical researchers study CAR-T and other immune cell ...
Creative Biolabs has launched an integrated OMV and exosome-boosted CAR-T development platform to help researchers overcome the major barriers that ha...
GeoVax Labs has entered a $1 million revolving loan agreement with Bowery Consulting Group, leading to the appointment of three new directors nominate...
TransCode Therapeutics announced that its Phase 1a trial of TTX-MC138 met its primary safety endpoint with no dose-limiting toxicities and showed dise...
Oncotelic Therapeutics announced a peer-reviewed study showing its AI-powered PDAOAI platform identified a four-gene prognostic signature in hepatocel...
The Trump administration's plan to ease restrictions on certain peptides could open a $2 billion to $3 billion market, drawing attention to companies ...
Tonix Pharmaceuticals will report third-quarter 2026 financial results and operational highlights on Nov. 9, giving investors a scheduled update on a ...
Coherence Neuro's $45 million Series A, co-led by Peter Thiel's Founders Fund and the OpenAI Startup Fund, will fund the first chronic human trial of ...
Adaptogenics Health Corp. is pursuing three complementary opportunities in the peptide sector—pharmaceutical-quality supply, proprietary therapeutics,...
Neovii Pharmaceuticals is advancing its ATLG program for Type 1 Diabetes into a pivotal Phase 2 study in the U.S. and EU, supported by FDA Fast Track ...
Annovis Bio will present three buntanetap studies at the 2026 CTAD conference, highlighting its Phase 3 Alzheimer's program ahead of a pivotal data re...
NeuroThera Labs has completed manufacturing and received European Qualified Person batch release for its investigational drug SCI-110, enabling shipme...
VERAXA Biotech is implementing FDA-aligned New Approach Methodologies across its preclinical research programs to generate more clinically informative...
VERAXA Biotech is developing antibody-based cancer therapies that aim to improve treatment selectivity and reduce toxicity, with promising preclinical...
The United States still leads China in biotechnology, but a new SCSP scorecard shows China ahead in industrial capacity and national leverage, with th...
SS Innovations International has launched Sri Lanka's first robotic cardiac surgery program at Kings Hospital Colombo using its SSi Mantra 3.0 system,...
